Paul Provakar, Karar Monaj, Alam Md Nur, Dutta Debanjan, Majumdar Tapas, Mallick Arabinda
Department of Chemistry, University of Kalyani, Nadia, Kalyani, West Bengal 741235, India.
Department of Life Sciences, Presidency University, Kolkata 700073 West Bengal, India.
ACS Appl Bio Mater. 2020 Nov 16;3(11):8049-8060. doi: 10.1021/acsabm.0c01121. Epub 2020 Nov 4.
In this article, pharmacological management of circumstantial overdose of an anticancer drug, Harmine (HM), under in vitro and in vivo conditions is described and further validated by employing in silico methods. HM, an efficient cancer cell photosensitizer, interacts extensively with nontoxic β-cyclodextrin (β-CD). Steady-state fluorescence studies and molecular docking analysis established differential nature of molecular inclusion depending on the relative concentrations of β-CD. Presently, β-CD is commonly used as a standard drug-delivery vehicle but its application for controlled drug withdrawal is rarely explored. Flow cytometric results and in vivo investigations on a zebrafish model showed that conditional overdose of preadministered drug molecules can be efficiently removed by encapsulating successfully within nontoxic β-CDs, albeit by controlled application of the same. This is an approach to manage the cytotoxicity of a drug in a safe way that is already administered. We believe that this β-CD-mediated withdrawal of drugs may find possible applications in controlled capturing of excess or unused drug inside living systems and reducing the unwanted toxicity associated with chemotherapeutics.
本文描述了在体外和体内条件下对抗癌药物哈尔明(HM)意外过量用药的药理学处理方法,并通过计算机模拟方法进一步验证。HM是一种有效的癌细胞光敏剂,与无毒的β-环糊精(β-CD)广泛相互作用。稳态荧光研究和分子对接分析确定了分子包合的差异性质取决于β-CD的相对浓度。目前,β-CD通常用作标准药物递送载体,但其在控制药物戒断方面的应用很少被探索。流式细胞术结果和对斑马鱼模型的体内研究表明,预先给药的药物分子的条件性过量可以通过成功封装在无毒的β-CD内而有效地去除,尽管需要控制其应用。这是一种以安全方式管理已给药药物细胞毒性的方法。我们相信,这种β-CD介导的药物戒断可能在控制捕获活体内多余或未使用的药物以及减少与化疗相关的不必要毒性方面找到可能的应用。